Chungbuk-Style Bio Open Innovation Bears Fruit
Two Companies Selected to Launch Short-Term Collaboration Projects

GC Biopharma said on November 11 that it held the “GC Biopharma x Chungbuk Bio Open Innovation Matching Day” with the Osong Advanced Medical Industry Promotion Foundation (KBIOHealth) on November 10 and selected two promising biotech startups to jointly validate next-generation biotech innovations.


The project is a local government-linked open innovation initiative supported by Chungcheongbuk-do and Cheongju City, led by KBIOHealth, with BioBook participating as the implementing organization.


GC Biopharma held the “GC Biopharma-Chungbuk Bio Open Innovation Matching Day” on the 10th with the Osong Medical Innovation Foundation (KBIOHealth). From left: Ha Jaesang, Acting Chairperson of KBIOHealth; Jung Jaewook, Head of R&D at GC Biopharma; Lee Bokwon, Vice Governor for Economic Affairs of Chungcheongbuk-do; and Shin Byeongdae, Deputy Mayor of Cheongju. GC Biopharma

GC Biopharma held the “GC Biopharma-Chungbuk Bio Open Innovation Matching Day” on the 10th with the Osong Medical Innovation Foundation (KBIOHealth). From left: Ha Jaesang, Acting Chairperson of KBIOHealth; Jung Jaewook, Head of R&D at GC Biopharma; Lee Bokwon, Vice Governor for Economic Affairs of Chungcheongbuk-do; and Shin Byeongdae, Deputy Mayor of Cheongju. GC Biopharma

View original image

The judging panel evaluated the companies with a focus on their relevance to technologies sought by GC Biopharma, technological competitiveness, and potential to create synergies through collaboration, ultimately selecting Neona and Mion as the partner companies.


With technical advice and validation support from GC Biopharma, the selected companies plan to begin short-term collaboration projects, or proofs of concept (PoCs).


KBIOHealth will provide the selected companies with collaboration project funding totaling 140 million won, with the amount varying by company. It also plans to provide follow-up support to high-performing companies in connection with initiatives such as the “Chungcheongbuk-do Advanced Medical Technology Value Creation Project.”



“Through this call for proposals, we confirmed the high technological potential of domestic biotech startups,” said Jung Jaeuk, head of R&D at GC Biopharma. “We will pursue close PoC projects with the selected companies to achieve meaningful research and development (R&D) results.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing